Compare Bristol-Myers Squibb Co (BMY) vs FirstEnergy Corp. (FE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs FirstEnergy Corp. — how do they compare? Bristol-Myers Squibb Co trades at $63.74 (market cap $132.45B), while FirstEnergy Corp. trades at $46.86 (market cap $27.06B). The key difference: Bristol-Myers Squibb Co is far larger — about 4.9× FirstEnergy Corp.'s market cap, and FirstEnergy Corp. pays the higher dividend (3.98%). Which is the better fit depends on your goals.
| BMY | FE | |
|---|---|---|
Market Cap | $132.45B | $27.06B |
Sector | Health | Utilities |
52-Week High | $65.89 | $51.91 |
52-Week Low | $42.60 | $42.83 |
Enterprise Value | $166.44B | $55.98B |
Dividend Yield | 3.89% | 3.98% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About FirstEnergy Corp.
FirstEnergy is one of the largest investor-owned utilities in the United States with 10 regulated distribution companies across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems with 24,000 miles of lines.
Read more on FE →
